Randomized Clinical Trial of Propofol, 1:1 and 4:1 Combination of Propofol and Ketamine for Procedural Sedation
Primary Purpose
Procedural Sedation
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Propofol
1:1 Propofol/Ketamine
4:1 Propofol/Ketamine
Sponsored by
About this trial
This is an interventional treatment trial for Procedural Sedation focused on measuring Deep Procedural Sedation, Propofol, Ketamine, Emergency Department, Monitoring, Capnography, Procedural Sedation in the Emergency Department
Eligibility Criteria
Inclusion Criteria:
- Adult patients undergoing procedural sedation for an urgent procedure in the Emergency Department
Exclusion Criteria:
- Allergy to propofol or ketamine, intoxication, altered mental status, ASA physical status score >2
Sites / Locations
- Hennepin County Medical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Experimental
Experimental
Arm Label
Propofol
1:1 Propofol/Ketamine
4:1 Propofol/Ketamine
Arm Description
Deep sedation using propofol
Propofol and ketamine mixed 1:1, given at 0.1 cc/kg as initial bolus, followed by 1/2 that dose every 3 minutes as need for sedation
Propofol and ketamine mixed 4:1, given at 0.1 cc/kg as initial bolus, followed by 1/2 that dose every 3 minutes as need for sedation
Outcomes
Primary Outcome Measures
Clinical Interventions During Sedation
Add/increase in supplemental oxygen, stimulation to induce respiration, airway repositioning, assisted ventilations, endotracheal intubation
Hypoxia
Pulse oximetry
Secondary Outcome Measures
Respiratory Depression
Continuous capnographic monitoring
Procedural Recall
After patients returned to baseline mental status they were asked whether they were able to recall any of the procedure. Question was answered in a yes or no format.
Full Information
NCT ID
NCT01260662
First Posted
December 13, 2010
Last Updated
June 15, 2015
Sponsor
Hennepin Healthcare Research Institute
1. Study Identification
Unique Protocol Identification Number
NCT01260662
Brief Title
Randomized Clinical Trial of Propofol, 1:1 and 4:1 Combination of Propofol and Ketamine for Procedural Sedation
Official Title
Randomized Blinded Three Arm Trial of Propofol, 1:1 Combination of Propofol and Ketamine, and 4:1 Combination of Propofol and Ketamine for Procedural Sedation in the Emergency Department
Study Type
Interventional
2. Study Status
Record Verification Date
June 2015
Overall Recruitment Status
Completed
Study Start Date
November 2010 (undefined)
Primary Completion Date
August 2013 (Actual)
Study Completion Date
August 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hennepin Healthcare Research Institute
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This will be a randomized trial of propofol versus the combination of propofol and ketamine for procedural sedation for procedures in the Emergency Department (ED). Propofol produces sedation, hypnosis, and dense amnesia, and is commonly used in the ED at Hennepin County Medical Center (HCMC) for procedural sedation. Ketamine is a dissociative anesthetic that is also frequently used in the ED in children and sometimes in adults. It has been proposed that by combining the two agents, the negative side effects of respiratory depression and hypotension associated with propofol, and the negative effects of dysphoria and vomiting associated with ketamine, can be avoided.
In the proposed study, patients seen in the ED who will require procedural sedation for a painful procedure will be randomized to receive either propofol or propofol and ketamine. During the procedure, patients will be monitored per the standard of care, including use of a cardiac monitor, non-invasive blood pressure monitoring, pulse oximetry, nasal sample end-tidal carbon dioxide, and physician assessment. Once the procedure is successfully completed and the patient has returned to his/her baseline mental status, the patient will be asked to mark a 100 mm visual analog scale regarding perceived pain during the procedure, memory of the procedure, and overall satisfaction with the procedure.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Procedural Sedation
Keywords
Deep Procedural Sedation, Propofol, Ketamine, Emergency Department, Monitoring, Capnography, Procedural Sedation in the Emergency Department
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
271 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Propofol
Arm Type
Active Comparator
Arm Description
Deep sedation using propofol
Arm Title
1:1 Propofol/Ketamine
Arm Type
Experimental
Arm Description
Propofol and ketamine mixed 1:1, given at 0.1 cc/kg as initial bolus, followed by 1/2 that dose every 3 minutes as need for sedation
Arm Title
4:1 Propofol/Ketamine
Arm Type
Experimental
Arm Description
Propofol and ketamine mixed 4:1, given at 0.1 cc/kg as initial bolus, followed by 1/2 that dose every 3 minutes as need for sedation
Intervention Type
Drug
Intervention Name(s)
Propofol
Intervention Description
1 mg/kg IV bolus followed by 0.5 mg/kg every 3 minutes as need for sedation
Intervention Type
Drug
Intervention Name(s)
1:1 Propofol/Ketamine
Intervention Description
Propofol and ketamine mixed 1:1, given at 1 mg/kg IV bolus followed by 0.5 mg/kg every 3 minutes as need for sedation
Intervention Type
Drug
Intervention Name(s)
4:1 Propofol/Ketamine
Intervention Description
Propofol and ketamine mixed 4:1, given at 1 mg/kg IV bolus followed by 0.5 mg/kg every 3 minutes as need for sedation
Primary Outcome Measure Information:
Title
Clinical Interventions During Sedation
Description
Add/increase in supplemental oxygen, stimulation to induce respiration, airway repositioning, assisted ventilations, endotracheal intubation
Time Frame
From start of sedation procedure to end of sedation procedure, up to 24 hours
Title
Hypoxia
Description
Pulse oximetry
Time Frame
From start of sedation procedure to end of sedation procedure, up to 24 hours
Secondary Outcome Measure Information:
Title
Respiratory Depression
Description
Continuous capnographic monitoring
Time Frame
From start of sedation procedure to end of sedation procedure, up to 24 hours
Title
Procedural Recall
Description
After patients returned to baseline mental status they were asked whether they were able to recall any of the procedure. Question was answered in a yes or no format.
Time Frame
Immediately after the end of the procedure, a single time point within 30 minutes of procedures conclusion.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Year
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult patients undergoing procedural sedation for an urgent procedure in the Emergency Department
Exclusion Criteria:
Allergy to propofol or ketamine, intoxication, altered mental status, ASA physical status score >2
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James R Miner, MD
Organizational Affiliation
Hennepin Healthcare Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hennepin County Medical Center
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55415
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
25441247
Citation
Miner JR, Moore JC, Austad EJ, Plummer D, Hubbard L, Gray RO. Randomized, double-blinded, clinical trial of propofol, 1:1 propofol/ketamine, and 4:1 propofol/ketamine for deep procedural sedation in the emergency department. Ann Emerg Med. 2015 May;65(5):479-488.e2. doi: 10.1016/j.annemergmed.2014.08.046. Epub 2014 Oct 16.
Results Reference
derived
Learn more about this trial
Randomized Clinical Trial of Propofol, 1:1 and 4:1 Combination of Propofol and Ketamine for Procedural Sedation
We'll reach out to this number within 24 hrs